What is Amcor's gross profit margin?

What does Amcor do and what are its main business segments?

What is the market's earnings forecast for Amcor next quarter?

What is the revenue and EPS growth rate for Amcor year over year?

What is Amcor's latest dividend and current dividend yield?

Did Amcor beat or miss consensus estimates last quarter?

What guidance did Amcor's management provide for the next earnings period?

What were the key takeaways from Amcor’s earnings call?

- **EPS Growth Beats Expectations**: Q1 EPS of $0.193 (+18% YoY) driven by $38 million synergies and cost control.
- **Strong Synergy Pipeline**: $70 million+ revenue synergies pipeline, reaffirming $260 million FY26 target.
- **Cash Flow Strength**: FY26 free cash flow guidance of $1.8-1.9 billion, up 100% YoY.
- **Dividend Increase**: $0.13 quarterly dividend reflects confidence in cash generation.
- **Operational Resilience**: EBIT up 4% despite 2% volume decline, driven by cost flexibility.


**【CEO Opening Remarks】**
- Amcor achieved EPS of $0.193 per share in Q1 FY26, up 18% YoY, driven by cost-out performance and synergy realization.
- Delivered $38 million in synergies (towards the upper end of guidance), with $70 million+ in revenue synergies pipeline.
- Aims to deliver $260 million in FY26 synergies and reaffirms FY26 EPS growth of 12-17%.
- Announces $0.13 quarterly dividend increase, reflecting confidence in cash flow generation.

**【CFO Financial Commentary】**
- Global Flexible Packaging: Net sales +25% (constant currency), EBIT margin 13.1%, up 20bps YoY.
- Global Rigid Packaging: Net sales +205% (constant currency), EBIT margin 11.9%, up 420bps YoY.
- Free cash flow outflow of $343 million (in line with expectations), with FY26 free cash flow guidance of $1.8-1.9 billion.
- Leverage at 3.6x, targeting 3.1-3.2x by year-end, supported by $100 million from asset sales.

**【Q&A Highlights】**
- **Volume Declines**: Volumes down 2% (excl. noncore NA Beverage), driven by macroeconomic softness, but EBIT up 4% due to cost management.
- **NA Beverage Business**: Operational issues resolved, profitability improving; exploring strategic alternatives.
- **Synergy Momentum**: $38 million Q1 synergies (G&A, procurement), with $260 million FY26 target reaffirmed.
- **Health Care Growth**: North America medical segment strong, Europe pharma lagging, but overall health care flat YoY.
- **Private Label Trends**: Consumer value-seeking driving private label growth, with Amcor underrepresented in key markets.


Amcor plc (AMCR) Q1 2026 Earnings Call Transcript

- **Berry Integration Milestone**: 100 days post-acquisition with $200+ headcount reductions and 5 site closures
- **FY26 Growth Target**: 12-17% EPS growth ($0.80-$0.83) driven by $260M synergies
- **NA Beverage Challenges**: Q4 EBIT down $20M due to operational inefficiencies; strategic review underway
- **Portfolio Optimization**: $2.5B non-core assets under review to focus on high-margin nutrition/health solutions
- **Cash Flow Strength**: FY26 free cash flow doubling to $1.8-1.9B despite macroeconomic headwinds

**【CEO Opening Remarks】**
- Announced completion of Berry Global acquisition, now 100 days into integration. 
- FY26 guidance: Adjusted EPS growth 12-17% ($0.80-$0.83), free cash flow doubling to $1.8-1.9B.
- Synergy target: $650M total by FY28 ($260M FY26), with $200+ headcount reductions and 5 site closures.
- Portfolio review: Core focus on nutrition/health solutions; $2.5B non-core assets under review (incl. $1.5B NA beverage). 

**【CFO Financial Review】**
- Q4 FY25 Results:
  - Global Flexibles: +18% net sales, 14.1% EBIT margin
  - Global Rigid: +121% net sales, 10.9% EBIT margin
  - Free cash flow $926M vs. guidance; FY26 FCF target $1.8-1.9B
- Key challenges:
  - NA beverage EBIT down $20M vs. prior year due to operational inefficiencies
  - Sequentially weaker volumes in Flexibles/Rigid (1.7% YoY decline)
- FY26 Outlook:
  - Flat volumes assumed; 42-45% of EPS growth in H1
  - $260M synergies (80% cost-related) driving 12% EPS accretion

**【Q&A Highlights】**
1. **NA Beverage Business**
   - Operational issues in Q4: $20M EBIT decline due to labor, freight costs
   - Management actions: New dedicated leadership, network optimization
   - Divestment timeline: No definite schedule; focus on performance improvement first

2. **Synergy Execution**
   - G&A savings: 200+ headcount reductions, 5 site closures
   - Procurement: $650M target unchanged despite potential divestments
   - Synergy phasing: 15% in Q1, 35% by H1, full run rate by Q4

3. **Strategic Portfolio**
   - Core focus: 75% of sales in advanced solutions, 50% in high-growth categories
   - Non-core assets: $2.5B in businesses with lower growth/margin profiles
   - Value-based pricing: Deploying Amcor best practices across Berry portfolio

Amcor plc (AMCR) Q4 2025 Earnings Call Transcript

- **Merger Success**: Early close enables $260M FY26 synergies, 12% EPS accretion, and $650M total over 3 years.
- **Q3 Performance**: $3.3B sales, 5% EPS growth, offset by North American beverage weakness (-high single digits).
- **Procurement Edge**: $13B combined raw material spend to drive 2-3% savings via scale and term optimization.
- **Dividend Signal**: +2% FY25 dividend growth despite macro uncertainty.

**【CEO Opening Remarks】**
- Announced successful early close of the Amcor-Berry Global merger, 6 months ahead of schedule, positioning for accelerated synergy delivery.
- Highlighted Q3 revenue growth driven by Europe, Asia Pacific, and Latin America, offset by weaker North American demand.
- Emphasized 12% EPS accretion from $260M FY26 synergies, with $650M total over 3 years, independent of macroeconomic conditions.
- Discussed portfolio pruning to focus on higher-value end markets and enhanced R&D capabilities ($180M annual investment).

**【CFO Financial Update】**
- Q3 net sales: $3.3B, EBIT: $384M, adjusted EPS up 5% YoY.
- Flexibles segment: Volumes +1%, EBIT +2% (13.7% margin), driven by healthcare and medical packaging growth.
- Rigid Packaging: Volumes -2%, EBIT down due to North American beverage weakness (-high single digits) and Latin America strength.
- FY25 guidance: EPS $0.72-$0.74, FCF $900M-$1B, including 2 months of Berry contribution.
- Leverage expected at 3.4x FY25, targeting 3.0x by FY26.

**【Key Q&A Highlights】**
- **North American Weakness**: Beverage volumes down high single digits Q3, driven by sticky inflation and tariff uncertainty. Health care and liquids offset declines.
- **Synergy Execution**: $260M FY26 synergies ($40% of total) achievable via SG&A/procurement cost savings, operations optimization, and growth initiatives.
- **Procurement Strategy**: Combined $13B raw material spend (70% overlap) enables 2-3% price/mix improvements, with early discussions with suppliers.
- **Dividend Growth**: FY25 dividend +2% YoY, signaling confidence in cash generation despite macro challenges.


Amcor (AMCR)-30 Apr 25-2025 Q3 Earnings call transcript

- **Q2 Growth Drivers**: 2.3% volume growth in Flexibles, 10% EBIT expansion in Rigid Packaging.
- **Merger Synergies**: $650M total, 35% EPS accretion, with $260M realized in Year 1.
- **Cash Efficiency**: Net debt reduced 10% QoQ, 3.3x leverage below target.
- **Healthcare Turnaround**: Pharma destocking ending, medical volumes up Q2.
- **FY25 Confidence**: Reaffirmed $0.72-$0.76 EPS, 3%-8% growth.

**【CEO Opening Remarks】**
- Q2 net sales of $3.2 billion, up 1% YoY, driven by 2.3% volume growth in Flexibles and 1% in Rigid Packaging.
- Adjusted EBIT up 5% YoY to $375 million, with margin expansion of 40bps to 11.7%.
- Reaffirmed FY25 guidance of $0.72-$0.76 EPS, with 3%-8% growth.
- Berry merger expected to close mid-2025, with $650M total synergies ($260M in Year 1) and 35% EPS accretion.

**【CFO Financial Breakdown】**
- **Flexibles Segment**: Q2 net sales $1.6B (+1% YoY), EBIT $322M (+4%), margin 12.8%.
  - Healthcare destocking impact abated, volumes up 4% ex-North America.
  - China/Asia demand strong, offsetting North America pharma softness.
- **Rigid Packaging**: Net sales $1.2B (-1% YoY), EBIT $103M (+10%), margin 8.5%.
  - Beverage volumes down mid-single digits, but improving sequentially.
  - Brazil/Latin America growth offset Argentina weakness.
- **Cash Flow**: Q2 free cash flow $350M, net debt reduced $375M to $3.3B (3.3x leverage).
- **Dividend**: $365M returned to shareholders YTD.

**【Key Synergy Highlights】**
- $650M total synergies ($40% in Year 1), including:
  - $325M procurement savings (3% of $13B combined spend)
  - $180M R&D optimization
  - $145M G&A/operational efficiency
- $280M one-time working capital benefits.

**【Q&A Key Takeaways】**
- **Healthcare Recovery**: Pharma destocking largely complete, medical volumes up Q2.
- **Raw Materials**: Benign price environment, <1% Q2 pass-through.
- **Integration Progress**: 1,500+ R&D staff aligned, 100-day plan finalized.
- **Tariffs Impact**: Minimal due to regional supply chains and pass-through agreements.
- **FY25 Outlook**: Volumes +3-5%, EBIT margin expansion, $900M+ free cash flow.

Amcor plc (AMCR) Q2 2025 Earnings Call Transcript

Amcor (AMCR)-31 Oct 24-2025 Q1 Earnings call transcript

Amcor (AMCR)-30 Apr 24-2024 Q3 Earnings call transcript

- **Cost Efficiency**: $200M+ H1 savings, 5% workforce reduction, $35M H2 structural savings.
- **Volume Recovery**: Q2 low point, Q4 EPS growth expected, healthcare destocking to continue.
- **Cash Flow Strength**: $850M-$950M free cash flow, 3.4x leverage (target 3x).
- **Segment Growth**: Asia (+2%), Latin America (+mid-single digits), protein packaging strategic investments.

**【CEO Summary Section】**
- **Safety Focus**: 70% of sites injury-free for 12+ months, 17% reduction in injuries YoY.
- **Financial Performance**: Q2 EPS modestly above expectations, $100M+ free cash flow YoY increase, $390M returned to shareholders.
- **Cost Management**: $200M+ cost savings H1, $130M in Q2 alone, 2,000+ headcount reductions (5% workforce).
- **Outlook**: Q2 volumes low point, Q4 EPS growth expected, healthcare destocking to continue.

**【CFO Financial Commentary】**
- **Segment Performance**: Flexibles down 8% YoY, Rigid Packaging down 8% YoY, Asia (+2%), Latin America (+mid-single digits).
- **Cash Flow**: $850M-$950M free cash flow guidance, 3.4x leverage (target 3x by end of FY).
- **Cost Initiatives**: $35M structural savings H2, $15M+ in FY25, $500M inventory reduction over 12 months.

**【Q&A Highlights】**
- **Volume Trends**: January improvement vs. Q2, healthcare and North American beverage destocking to persist.
- **Promotional Spending**: No direct impact on volumes yet, cautious on consumer demand recovery.
- **Argentina Operations**: 2% of sales, localized cost management, 55% devaluation impact in Q2.
- **Protein Packaging**: Equipment acquisition strategy, long-term growth aspirations, short-term destocking headwinds.

AMCR

AMCR fundamentals

Earnings Call

You can ask Aime